UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________ Form 10-Q ________________________________________________________________________________ ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commiss ...

LifeVantage Corporation (NASDAQ:LFVN) Q4 2022 Earnings Conference Call August 23, 2022 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today’s conference call to discuss LifeVantage’s Fourth Quarter and Full Fiscal Year 2022 Results. At this time, all participants are in a listen-only mode. Following the formal remarks, we wi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended June 30, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from __________ to __________ Commission file number: 001-35647 ________________________________________ ...

LifeVantage Corporation (NASDAQ:LFVN) Q3 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - CEO Carl Aure - CFO Conference Call Participants Doug Lane - Lane Research Anthony Chiarenza - Key Equity Investors Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today’s conference call to discuss LifeVantage’s Third Quarter Fiscal 2022 Results. At this time, all participants are in a listen-only mode. Following the formal remark ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________ Form 10-Q ________________________________________________________________________________ ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO (Address of ...

LifeVantage Corporation (NASDAQ:LFVN) Q2 2022 Earnings Conference Call February 1, 2022 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Doug Lane - Lane Research Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________ Form 10-Q ________________________________________________________________________________ ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commissi ...

LifeVantage Corporation (NASDAQ:LFVN) Q1 2022 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Reed Anderson - Senior Vice President, ICR, IR Steve Fife - Chief Executive Officer Justin Rose - Chief Sales and Marketing Officer Carl Aure - Chief Financial Officer Conference Call Participants Doug Lane - Lane Research Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today’s conference call to discuss LifeVantage’s First Quarter of 2022 Results. At this ti ...

Form 10-Q ________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D.C. 20549 ________________________________________________________________________________ FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commiss ...

LifeVantage Corporation (NASDAQ:LFVN) Q4 2021 Earnings Conference Call August 19, 2021 4:30 PM ET Company Participants Reed Anderson - Senior Vice President, ICR, IR Steve Fife - CEO and CFO Justin Rose - Chief Sales and Marketing Officer Conference Call Participants Doug Lane - Lane Research Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Fourth Fiscal Quarter of 2021 Financial Results. At this time, all participants are in a l ...